The sunshine act and medical publications: Guidance from professional medical associations.

نویسندگان

  • Dikran Toroser
  • Lisa DeTora
  • Angela Cairns
  • Renu Juneja
  • Anna Georgieva
  • Al Weigel
  • Kim Pepitone
چکیده

OBJECTIVE To review guidance from professional medical associations to physicians on the Sunshine Act, with a focus on industry support for medical publications. METHODS Using 'Sunshine Act' as a search term, we searched PubMed (dates February 2013 to November 2014) and the 'grey literature' using Google and Google Scholar. Online information was extracted from websites of pre-identified professional medical associations. RESULTS Some professional medical associations have published peer-reviewed recommendations, position statements or general advice on their websites and in journals around the Sunshine Act. Associations also provided broad online educational resources for physicians. There was universal agreement between peer-reviewed publications, including guidelines, for the need for full transparency and disclosure of industry support. Surveys by some professional associations showed variance in opinion on the forecasted impact of the Sunshine Act on physician-industry relationships. There was scarce information specifically related to reporting requirements for industry-supported medical publications. CONCLUSIONS There is a shortage of information for physicians from professional associations regarding the Sunshine Act and support for medical publications. Due to the lack of clear guidance regarding support for publications, there are presently varying interpretations of the Sunshine Act. The literature debates the potential impact of the Sunshine Act and expresses some concerns that physician-enabled innovation in drug development may be hindered.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Systematic review of reports describing potential impact of the Sunshine Act on peer-reviewed medical publications.

OBJECTIVE The Physician Payments Sunshine Act, enacted in 2010, is intended to increase the transparency of relationships between US physicians and teaching hospitals and manufacturers of drugs, biologics, and medical devices. We examined current opinion regarding the impact of the Sunshine Act on peer-reviewed medical publications. RESEARCH DESIGN AND METHODS We searched indexed databases (N...

متن کامل

A physician-driven solution--the Association for Medical Ethics, the Physician Payment Sunshine Act, and ethical challenges in pain medicine.

The practice of contemporary pain medicine is laced with a number of significant ethical challenges. Considerable difficulties include the overutilization of interventional procedures, the application of under-evidenced treatment modalities, and potentially superfluous opioid prescribing. As with many other fields in medicine, including orthopedic surgery, relationships with industry are both c...

متن کامل

The Sunshine Act: Commercial conflicts of interest and the limits of transparency

We must create a world in which the best experts are those that are free from commercial influence. And Europe needs legislation along the lines of the US Sunshine Act to combat both real and perceived commercial influence in science and health care. Sunshine Act, which became federal law in the United States in January 2012. 2 The Act requires drug and medical manufacturers who participate in ...

متن کامل

Devotion for newborn children

“ROMMEDICA Medical Instruments and Equipment International Fair –” took place at Romexpo Exhibition Center in Bucharest between the 14th and the 16th of April 2016. The event, which represented an important source of information for the representatives of the health system in the public and private sector, was and still is the most important annual meeting place for the specialists in medicine ...

متن کامل

Good publication practice for pharmaceutical companies.

Guidelines on Good Publication Practice (GPP) for pharmaceutical companies are presented. The aim of the guidelines is to ensure that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner. The guidelines cover companies' responsibility to an endeavour to publish results of all studies, companies' relations with investigators, measures to prevent...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Postgraduate medicine

دوره 127 7  شماره 

صفحات  -

تاریخ انتشار 2015